David Campbell
5PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 31, 2026
Number needed to treat to avoid progression and death and cost analysis: zanubrutinib versus acalabrutinib in relapsed/refractory chronic lymphocytic leukemia.Mazyar Shadman, Asher Chanan-Khan, David Campbell
|Sep 13, 2025
Diagnosis, Treatment, and Unmet Needs of Dedifferentiated Liposarcoma in the United States: A Multidisciplinary Delphi Study.David Campbell, Scott Ramsey, David Veenstra
|Jul 25, 2025
A Value Framework for Evaluating Population Genomic Programs: A Mixed Methods Approach.David Campbell, Scott Spencer, Ashley Kang
|Apr 01, 2021
Primary Prophylaxis With Biosimilar Filgrastim for Patients at Intermediate Risk for Febrile Neutropenia: A Cost-Effectiveness Analysis.Edward Li, Dylan J Mezzio, David Campbell
|Nov 28, 2018
The present and future burden of previously treated advanced non-small cell lung cancer (NSCLC) by histology and line of therapy in France, Germany, Italy, and Spain: model-based predictions.David Campbell, Ken O'Day, Nadine Hertel
Pageof 1
Frequent Collaborators
1 joint publications
Edward Li
1 joint publications
Gary H Lyman
1 joint publications
Ashley Kang
1 joint publications
Sarah Katsandres
1 joint publications
Minggui Pan
1 joint publications
Andrew Fang
1 joint publications
Mazyar Shadman
1 joint publications
Asher Chanan-Khan
1 joint publications
Mei Xue
1 joint publications
Marjan Massoudi
